Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory testing for heparin-induced thrombocytopenia.

× No keyword cloud information.

41 in total

1. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

Authors: J Amiral; F Bridey; M Dreyfus; A M Vissoc; E Fressinaud; M Wolf; D Meyer
Journal: Thromb Haemost Date: 1992-07-06 Impact factor: 5.249

Review 2. Heparin-induced thrombocytopenia: towards consensus.

Authors: T E Warkentin; B H Chong; A Greinacher
Journal: Thromb Haemost Date: 1998-01 Impact factor: 5.249

3. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.

Authors: T L Bauer; G Arepally; B A Konkle; B Mestichelli; S S Shapiro; D B Cines; M Poncz; S McNulty; J Amiral; W W Hauck; R N Edie; J D Mannion
Journal: Circulation Date: 1997-03-04 Impact factor: 29.690

4. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome.

Authors: J I Almeida; R Coats; T K Liem; D Silver
Journal: J Vasc Surg Date: 1998-02 Impact factor: 4.268

5. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.

Authors: C Bachelot-Loza; R Saffroy; D Lasne; G Chatellier; M Aiach; F Rendu
Journal: Thromb Haemost Date: 1998-03 Impact factor: 5.249

6. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia.

Authors: A Tomer
Journal: Br J Haematol Date: 1997-09 Impact factor: 6.998

7. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.

Authors: J G Kelton; J W Smith; T E Warkentin; C P Hayward; G A Denomme; P Horsewood
Journal: Blood Date: 1994-06-01 Impact factor: 22.113

8. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay.

Authors: A Greinacher; J Amiral; V Dummel; A Vissac; V Kiefel; C Mueller-Eckhardt
Journal: Transfusion Date: 1994-05 Impact factor: 3.157

9. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

Authors: G P Visentin; S E Ford; J P Scott; R H Aster
Journal: J Clin Invest Date: 1994-01 Impact factor: 14.808

10. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.

Authors: T E Warkentin; C P Hayward; C A Smith; P M Kelly; J G Kelton
Journal: J Lab Clin Med Date: 1992-09

3 in total

Review 1. Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors: Albrecht Leo; Susanne Winteroll
Journal: Clin Diagn Lab Immunol Date: 2003-09

2. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.

Authors: E Magnus Ohman; Christopher B Granger; Lawrence Rice; Charles S Abrams; Richard C Becker; Peter B Berger; Neal S Kleiman; David Moliterno; Stephan Moll; Jo E Rodgers; Stephen S Steinhubl; Victor F Tapson; Peter Sinnaeve; Kevin J Anstrom
Journal: J Thromb Thrombolysis Date: 2005-02 Impact factor: 2.300

Review 3. Venovenous Extracorporeal Membrane Oxygenation in Intractable Pulmonary Insufficiency: Practical Issues and Future Directions.

Authors: T S R Delnoij; R Driessen; A S Sharma; E A Bouman; U Strauch; P M Roekaerts
Journal: Biomed Res Int Date: 2016-04-05 Impact factor: 3.411

3 in total